Talking Points: Full FDA Approval – Pfizer COVID-19 Vaccine
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
Immunization and Maternal Child Health Programs: Ideas for Partnering to Protect Women and Children
Explore AIM’s one-pager about collaboration opportunities between immunization programs (IPs) and maternal child health (MCH) programs.
AIM Legislative Round-Up: March 4, 2022
Legislative sessions are in full swing, and AIM is ready to support you. Read AIM's Legislative Round-Up for the latest immunization-related legislation items.
Legislative Roundup: March 4, 2022
Most legislative sessions are now in full swing, and AIM continues to stand ready to support you as you navigate these potentially challenging waters. View the short video of tips…
Flu Season Questions and Answers
This iREACH Q&A document provides information about the end of flu season and lists strategies that can be used to encourage people to get a flu vaccine.
Eastern Michigan University/Center for Health Disparities Innovations and Studies: Utilizing Listening Sessions to Assess COVID-19 Vaccine Acceptance among Asian Americans in Michigan
View a published paper detailing how Asian ethnic groups in Southeast Michigan were impacted by COVID-19 and how they viewed COVID-19 vaccines.
Events
See all the events, meetings, and webinars AIM and our partners are hosting in the coming months.
City of Hartford: Vacúnate Contra el Flu Social Media Graphic
View a Spanish-language social media graphic created to encourage flu vaccination in Hartford, Connecticut.
Long COVID Information and Resources
This talking points document was developed by the iREACH Subject Matter Experts to provide information and resources on long COVID-19.
AIM Statement on COVID-19 Vaccine Safety
Association of Immunization Managers (AIM) Executive Director Claire Hannan has issued this statement regarding recent comments made across public health regarding COVID19 vaccine development and forthcoming distribution.